Is seladin-1 really a selective alzheimer's disease indicator?

Journal of Alzheimer's Disease

Volumn 30, Issue 1, 2012, Pages 35-39

  Sharpe, Laura J ^a   Wong, Jenny ^b   Garner, Brett ^b   Halliday, Glenda M ^a   Brown, Andrew J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Alzheimer's disease; brain; cholesterol; DHCR24; neuroprotective; Seladin 1

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; SELECTIVE ALZHEIMER DISEASE INDICATOR 1 PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CATALYSIS; CEREBELLUM; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; OCCIPITAL CORTEX; PRIORITY JOURNAL; TEMPORAL CORTEX;

EID: 84861498444     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111955     Document Type: Article

References (27)

1. Peri A, Serio M (2008) Neuroprotective effects of the Alzheimer's disease-related gene seladin-1. J Mol Endocrinol 41, 251-261.
2. Nitsch RM, Greeve I (2008) Methods of diagnosing or treating neurological diseases and cell degeneration, Evotec Neuro Sciences GmbH. United States Patent number: 20080261302.
3. Ramos MC, Sierra S, Ramirez C, Velasco J, Burgos JS (2012) Simvastatin modulates the Alzheimer's disease-related gene seladin-1. J Alzheimers Dis 28, 297-301.
4. Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau B, Nitsch RM (2000) The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegener-ation and oxidative stress. J Neurosci 20, 7345-7352.
5. Iivonen S, Hiltunen M, Alafuzoff I, Mannermaa A, Kerokoski P, Puolivali J, Salminen A, Helisalmi S, Soininen H (2002) Seladin-1 transcription is linked to neuronal degeneration in Alzheimer's disease. Neuroscience 113, 301-310. (Pubitemid 34786175)
6. Lamsa R, Helisalmi S, Hiltunen M, Herukka SK, Tapiola T, Pirttila T, Vepsalainen S, Soininen H (2007) The association study between DHCR24 polymorphisms and Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 144B, 906-910. (Pubitemid 47547992)
7. Swaminathan S, Shen L, Risacher SL, Yoder KK, West JD, Kim S, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust WJ, Koeppe RA, Mathis CA, Jack CR Jr, Weiner MW, Saykin AJ (2012) Amyloid pathway-based candidate gene analysis of [(11) C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Brain Imaging Behav 6, 1-15.
8. Tedde A, Cellini E, Bagnoli S, Sorbi S, Peri A (2008) Muta-tional screening analysis ofDHCR24/seladin-1 geneinItalian familial Alzheimer's disease. Am J Med Genet B Neuropsy-chiatr Genet 147B, 117-119.
9. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW (2004) Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 101, 2173-2178. (Pubitemid 38229034)
10. Blalock EM, Buechel HM, Popovic J, Geddes JW, Landfield PW (2011) Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease. J Chem Neuroanat 42, 118-126.
11. Dunckley T, Beach TG, Ramsey KE, Grover A, Mas-troeni D, Walker DG, LaFleur BJ, Coon KD, Brown KM, Caselli R, Kukull W, Higdon R, McKeel D, Morris JC, Hulette C, Schmechel D, Reiman EM, Rogers J, Stephan DA (2006) Gene expression correlates of neurofibrillary tangles in Alzheimer's disease. Neurobiol Aging 27, 1359-1371. (Pubitemid 44279890)
12. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Ramsey K, Caselli RJ, Kukull WA, McKeel D, Morris JC, Hulette CM, Schmechel D, Reiman EM, Rogers J, Stephan DA (2008) Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: A reference data set. Physiol Genomics 33, 240-256. (Pubitemid 351629532)
13. Gregory GC, Macdonald V, Schofield PR, Kril JJ, Halliday GM (2006) Differences in regional brain atrophy in genetic forms of Alzheimer's disease. Neurobiol Aging 27, 387-393. (Pubitemid 43186040)
14. Kim WS, Bhatia S, Elliott DA, Agholme L, Kagedal K, McCann H, Halliday GM, Barnham KJ, Garner B (2010) Increased ATP-binding cassette transporter A1 expression in Alzheimer's disease hippocampal neurons. J Alzheimers Dis 21, 193-205.
15. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034.
16. Sarajarvi T, Haapasalo A, Viswanathan J, Makinen P, Laiti-nen M, Soininen H, Hiltunen M (2009) Down-regulation of seladin-1 increases BACE1 levels and activity through enhanced GGA3 depletion during apoptosis. J Biol Chem284, 34433-34443.
17. Waterham HR, Koster J, Romeijn GJ, Hennekam RCM, Vreken P, Andersson HC, Fitz Patrick DR, Kelley RI, Wanders RJA (2001) Mutations in the 3beta-hydroxysterol delta24-reductase gene cause desmosterolosis, anautosomal recessive disorder of cholesterol biosynthesis. Am J Hum Genet 69, 685-694. (Pubitemid 32868514)
18. Vanmierlo T, Bloks VW, van Vark-van der Zee LC, Rutten K, Kerksiek A, Friedrichs S, Sijbrands E, Steinbusch HW, Kuipers F, Lutjohann D, Mulder M (2010) Alterations in brain cholesterol metabolism inthe APPSLxPS1mut mouse, a model for Alzheimer's disease. J Alzheimers Dis 19, 117-127.
19. Köhler C, Ebert U, Baumann K, Schröder H (2005) Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels. Neurobiol Dis 20, 528-540. (Pubitemid 41476279)
20. Crameri A, Biondi E, Kuehnle K, Lutjohann D, Thelen KM, Perga S, Dotti CG, Nitsch RM, Ledesma MD, Mohajeri MH (2006) The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO J 25, 432-443. (Pubitemid 43152863)
21. Ledesma MD, Abad-Rodriguez J, Galvan C, Biondi E, Navarro P, Delacourte A, Dingwall C, Dotti CG (2003) Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains. EMBO Rep 4, 1190-1196. (Pubitemid 38088415)
22. Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, Delacourte A, Dingwall C, De Strooper B, Dotti CG (2004) Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 167, 953-960. (Pubitemid 39628117)
23. Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M, Girones X, Henry TL, Matsub-ara E, Zambon D, Wolozin B, Sano M, Cruz-Sanchez FF, Thal LJ, Petanceska SS, Refolo LM (2003) Mild hyperc-holesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61, 199-205. (Pubitemid 36875301)
24. Stefani M, Liguri G (2009) Cholesterol in Alzheimer's disease: Unresolved questions. Curr Alzheimer Res 6, 15-29.
25. Haag MD, Hofman A, Koudstaal PJ, Stricker BH, Breteler MM (2009) Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry 80, 13-17.
26. Biondi E (2011) Prescription of lipophilic statins to Alzheimer's disease patients: Some controversies to consider. Neurol Sci 32, 195-201.
27. Thelen KM, Rentsch KM, Gutteck U, Heverin M, Olin M, Andersson U, von Eckardstein A, Björkhem I, Lütjohann D (2006) Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin. J Pharmacol Exp Therap 316, 1146-1152. (Pubitemid 43345288)